Rare diseases affect millions of people around the world. Dr. Matt Might is Professor and Director of the Hugh Kaul Precision Medicine Institute at the University of Alabama Birmingham. His son, Bertrand, was the first person to be diagnosed with NGLY1 deficiency, an ultra-rare disorder. Matt joined me to discuss Bertrand’s diagnostic odyssey and the impact of genomics on rare disease research.
Audio PlayerFor the best experience using our website, we recommend that you upgrade to a newer version or use another web browser. A list of the most popular web browsers can be found below.
Click on an icon below to go to the download page or close this notice to continue with the current experience.